Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
6.27
+0.03 (0.48%)
Jan 21, 2026, 4:00 PM EST - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $12.03 million as of January 22, 2026. Its market cap has decreased by -46.54% in one year.
Market Cap
12.03M
Enterprise Value
3.71M
1-Year Change
-46.54%
Ranking
Category
Stock Price
$6.27
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $12.03M, a decrease of -98.26%. That is a compound annual growth rate of -55.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 12.03M | 14.67% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 12.71M |
| Curis | 12.52M |
| BioLineRx | 12.38M |
| Sensei Biotherapeutics | 12.12M |
| CytoMed Therapeutics | 12.12M |
| Edesa Biotech | 12.08M |
| Akari Therapeutics, | 11.90M |
| Imunon | 11.77M |